News
The company had previously halted shipments to certain older patients following the deaths of two teenagers treated with the ...
The FDA oncologic drugs advisory committee voted against the approval of GSK’s blood cancer treatment Blenrep, delivering a setback to the drugmaker’s efforts to reintroduce the drug to the U.S.
More than 67,000 cases of deodorant sold at major retailers are being recalled due to a manufacturing issue. According to a ...
Tayler said the FDA’s own research has highlighted that fact. “In the last National Youth Tobacco Survey, they asked youths if they used mint or menthol flavored and nearly 60% of them did,” she said.
Shares of Sarepta Therapeutics (NASDAQ:SRPT) continued to fall on Friday as Reuters reported that the U.S. FDA plans to ...
President Trump says Coca-Cola will swap out high-fructose corn syrup with cane sugar. Here’s what research says about its ...
Explore more
The FDA will request Sarepta Therapeutics stop all shipments of Elevidys, its gene therapy for Duchenne muscular dystrophy, ...
Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its approved gene therapy appeared at risk.
An FDA advisory committee ruled in two separate votes that two belantamab mafodotin combination regimens should not be used in the proposed dosages for previously treated adult patients with ...
The U.S. Food & Drug Administration has granted orphan drug designation to Chicago-based Amphix Bio's treatment for acute ...
The U.S. Food and Drug Administration will request Sarepta Therapeutics to voluntarily stop all shipments of its gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results